Lin BioScience, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias (NCT05756322) | Lin BioScience, Inc | 2023-07-20 |
Track Lin BioScience, Inc automatically
Every clearance here is in the API, with alerts when new ones post.